Czech J. Food Sci., 2001, 19(3):106-110 | DOI: 10.17221/6585-CJFS

Extract from Silybum marianum as a nutraceutical: a double-blind placebo-controlled study in healthy young men

V. ©imánek, N. ©kottová, J. Bartek, J. Psotová, P. Kosina, L. Balejová, J. Ulrichová
2 3 1 1 VILÍM ©IMÁNEK , NINA ©KOTTOVÁ , JOSEF BARTEK , JITKA PSOTOVÁ , PAVEL KOSINA , 3
1 LIBU©E BALEJOVÁ and JITKA ULRICHOVÁ

In a randomized, double-blind, placebo-controlled study, the effect of an extract from Silybum marianum seeds (ESM, milk thistle extract) on lipid and liver parameters and the antioxidant capacity of serum was investigated in 29 healthy men aged 18-32 years. They received either 858 mg of ESM (531 mg silymarin complex calculated on pure silibinin), or placebo, daily for the period of 60 days. No side effects were found. A routine biochemical analysis of the serum was performed as a measure of lipid and liver metabolism. Positive trend towards decreased serum cholesterol level and HDL-cholesterol increase was observed in the ESM group as compared to the placebo group. The serum antioxidant capacity was significantly higher in the ESM group. The results suggest the use of ESM as a dietary supplement for hypercholesterolemia.

Keywords: Silybum marianum; silymarin complex; double-blind; randomised placebo-controlled study; cholesterol; HDL; antioxidant status; nutraceutical

Published: June 30, 2001  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
©imánek V, ©kottová N, Bartek J, Psotová J, Kosina P, Balejová L, Ulrichová J. Extract from Silybum marianum as a nutraceutical: a double-blind placebo-controlled study in healthy young men. Czech J. Food Sci. 2001;19(3):106-110. doi: 10.17221/6585-CJFS.
Download citation

References

  1. BIOGK G., STROEDTER L., HERBST H., WALDSCHMIDT J., RIECKEN E.O., SCHUPPAN D. (1997): Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats. Hepatology, 26: 643-649. Go to original source... Go to PubMed...
  2. BUEGE J.A., AUST S.D. (1978): Microsomal lipid peroxidation. In: Methods in Enzymology, 52: 302-310. Go to original source... Go to PubMed...
  3. DEHMLOW C., ERHARD J., DE GROOT H. (1996): Inhibition of Kuffer cell functions as an explanation for the hepatoprotective properties of silibinin. Hepatology, 23: 749-753. Go to original source... Go to PubMed...
  4. DORANT E., VAN DEN BRANDT P.A., GOLDBOHM R.A., STURMANS F. (1996): Consumption of onions and a reduced risk of stomach carcinoma. Gastroenterology, 110: 12-20. Go to original source... Go to PubMed...
  5. FLORA K., HAHN M., ROSEN H., BENNER K. (1998): Milk thistle (Silybum marianum) for therapy of liver disease. Am. J. Gastroenterology, 93: 139-143. Go to original source... Go to PubMed...
  6. HERTOG M.G.L., FESKENS E.J.M., HOLLMAN P.C.H., KATAN M.B., KROMHOUT D. (1993): Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet, 342: 1007-1011. Go to original source... Go to PubMed...
  7. HU M.-L. (1994): Measurement of protein thiol groups and glutathione in plasma. In: Methods in Enzymology, 233: 380- 385. Go to original source... Go to PubMed...
  8. KOHEN R., VELLAICGAMY E., HRBAC J., GATI I., TIROSH O. (2000): Quantification of the overall reactive oxygen species scavenging capacity of biological fluids and tissues. Free Rad. Biol. Med., 28: 871-879. Go to original source... Go to PubMed...
  9. KOSINA P., BARTEK J. (2000): Determination of silybin in blood plasma using high performance liquid chromatography with solid phase extraction. Chem. Listy, 94: 1115-1117.
  10. K REÈMAN L., © KOTTOVÁ N., W ALTEROVÁ D., ULRICHOVÁ J., ©IMÁNEK V. (1998): Silymarin inhibits the development of diet - induced hypercholesterolemia in rats. Planta Med., 64: 138-142. Go to original source... Go to PubMed...
  11. KØEN V., SEDMERA P., KUBISCH J., HALADA P., PØIKRYLOVÁ V., JEGOROV A., CVAK L., GEBHARDT R., ULRICHOVÁ J., ©IMÁNEK V. (1997): Glycosylation of silybin. J. Chem. Soc., Perkin, 1: 2467-2474. Go to original source...
  12. MARTINDALE - The extra pharmacopeis. In: REYNOLDS E.F. (Ed.) (1998). The Pharmaceutical Press, London.
  13. MIETTINEN T.A. PUSKA P., GYLLING H., VANHANEN H., VARTIAINEN E. (1995): Reduction of serum cholesterol with sitostanol-ester margarine in mildly hypercholesterolemic population. New Eng. J. Med., 333: 1308-1312. Go to original source... Go to PubMed...
  14. MORAZZONI P., BOMBARDELLI E. (1995): Silybum marianum (Carduus marianus). Fitoterapia, 64: 3-42.
  15. PIETRANGELO A., BORELLA F., CASALGRANDI G., MONTOSI G., CECCARELLI D., GALLESI D., GIOVANNINI F., GASPARETTO A., MASINI A. (1995): Antioxidant activity of silybin in vivo during long-term iron overload in rats. Gastroenterology, 109: 1941-1949. Go to original source... Go to PubMed...
  16. SCHUPPAN D., JIA JI-DONG, BRINKHAUS B., HAHN E.G. (1999): Herbal products for liver diseases: A therapeutic challenge for the new millennium. Hepatology, 30: 1099- 1104. Go to original source... Go to PubMed...
  17. ©IMÁNEK V., KØEN V., ULRICHOVÁ J., VIÈAR J., CVAK L. (2000): Silymarin - What is in the name? Hepatology, 32: 442-443. ©KOTTOVÁ N., KREÈMAN V., CHMELA Z., ULRICHOVÁ J., ©IMÁNEK V. (2000): Influence of silymarin and silibininphosphatidylcholine complex on currant oil diet-induced changes of plasma lipoproteins and oxidizability of LDL in rats fed on high-cholesterol diet. In: Atherosclerosis. XIIth Int. Symp., Oslo, June 22-24, P025.
  18. ©KOTTOVÁ N., KREÈMAN V., ©IMÁNEK V. (1999): Activities of silymarin and its flavonolignans upon low density lipoprotein oxidizability in vitro. Phytother. Res., 13: 535-537. Go to original source...
  19. SONNENBICHLER J., S CALERA F., SONNENBICHLER I., WEYHENMEYER R. (1999): Stimulatory effects of silibinin and silicristin from the Milk thistle Silybum marianum on kidney cells. J. Pharm. Exper. Therap., 290: 1375-1383. Go to original source...
  20. WAGNER H., HORHAMMER L., MUNSTER R. (1968): On the chemistry of silymarin (silybin), the active principle of the fruits from Silybum marianum (L.) Gaertn. (Carduus marianus L.). Arzneimittelforsch., 18: 688-696. Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.